You are using an outdated browser. For a faster, safer browsing experience, upgrade for free today.

Pharma & Healthcare

Global Flunixin Meglumine Injection Market Research Report 2021 Professional Edition

Flunixin Meglumine Injection is used for febrile diseases, muscle pain and soft tissue pain of livestock and small animals
Market Analysis and Insights: Global Flunixin Meglumine Injection Market
The global Flunixin Meglumine Injection market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
Global Flunixin Meglumine Injection Scope and Segment
The global Flunixin Meglumine Injection market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Flunixin Meglumine Injection market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2016-2027.
The major regions covered in the report are North America, Europe, Asia-Pacific, South America, Middle East & Africa, etc. The report has specifically covered major countries including United States, Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia, Mexico, Brazil, Turkey, Saudi Arabia, UAE, etc. It includes revenue and volume analysis of each region and their respective countries for the forecast years. It also contains country-wise volume and revenue from the year 2016 to 2021. Additionally, it provides the reader with accurate data on volume sales according to the consumption for the same years.
By the product type, the market is primarily split into
10ml/Dose
20ml/ Dose
By the end users/application, this report covers the following segments
Animal muscle pain
Animal febrile disease
Others
Competitive Landscape:
The report provides a list of all the key players in the Flunixin Meglumine Injection market along with a detailed analysis of the strategies, which the companies are adopting. The strategies mainly include new product Developments, research, and Developments, and also provides revenue shares, company overview, and recent company Developments to remain competitive in the market.
The Flunixin Meglumine Injection key manufacturers in this market include:
Norbrook
Zoteis
Merck Animal Health
Virbac Animal Health India Private Limited
MSD Animal Health
Bengal Remedies Limited
Wuhan Huisheng Biological Technology Co., Ltd.
Qilu Animal Health Products Co., Ltd.
Baimukang Animal Pharmaceutical Co., Ltd.
Shandong Zhongmu Veterinary Medicine Co., Ltd.
Hebei New Century Pharmaceutical Co., Ltd.
Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd.
Shandong Lukang Pharmaceutical Co., Ltd.
1 Flunixin Meglumine Injection Market Overview
1.1 Flunixin Meglumine Injection Product Overview
1.2 Flunixin Meglumine Injection Market Segment by Type
1.2.1 10ml/Dose
1.2.2 20ml/ Dose
1.3 Global Flunixin Meglumine Injection Market Size by Type
1.3.1 Global Flunixin Meglumine Injection Market Size Overview by Type (2016-2027)
1.3.2 Global Flunixin Meglumine Injection Historic Market Size Review by Type (2016-2021)
1.3.2.1 Global Flunixin Meglumine Injection Sales Breakdown in Volume by Type (2016-2021)
1.3.2.2 Global Flunixin Meglumine Injection Sales Breakdown in Value by Type (2016-2021)
1.3.2.3 Global Flunixin Meglumine Injection Average Selling Price (ASP) by Type (2016-2021)
1.3.3 Global Flunixin Meglumine Injection Forecasted Market Size by Type (2022-2027)
1.3.3.1 Global Flunixin Meglumine Injection Sales Breakdown in Volume by Type (2022-2027)
1.3.3.2 Global Flunixin Meglumine Injection Sales Breakdown in Value by Type (2022-2027)
1.3.3.3 Global Flunixin Meglumine Injection Average Selling Price (ASP) by Type (2022-2027)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Flunixin Meglumine Injection Sales Breakdown by Type (2016-2021)
1.4.2 Europe Flunixin Meglumine Injection Sales Breakdown by Type (2016-2021)
1.4.3 Asia-Pacific Flunixin Meglumine Injection Sales Breakdown by Type (2016-2021)
1.4.4 Latin America Flunixin Meglumine Injection Sales Breakdown by Type (2016-2021)
1.4.5 Middle East and Africa Flunixin Meglumine Injection Sales Breakdown by Type (2016-2021)

2 Global Flunixin Meglumine Injection Market Competition by Company
2.1 Global Top Players by Flunixin Meglumine Injection Sales (2016-2021)
2.2 Global Top Players by Flunixin Meglumine Injection Revenue (2016-2021)
2.3 Global Top Players Flunixin Meglumine Injection Price (2016-2021)
2.4 Global Top Manufacturers Flunixin Meglumine Injection Manufacturing Base Distribution, Sales Area, Product Type
2.5 Flunixin Meglumine Injection Market Competitive Situation and Trends
2.5.1 Flunixin Meglumine Injection Market Concentration Rate (2016-2021)
2.5.2 Global 5 and 10 Largest Manufacturers by Flunixin Meglumine Injection Sales and Revenue in 2020
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Flunixin Meglumine Injection as of 2020)
2.7 Date of Key Manufacturers Enter into Flunixin Meglumine Injection Market
2.8 Key Manufacturers Flunixin Meglumine Injection Product Offered
2.9 Mergers & Acquisitions, Expansion

3 Flunixin Meglumine Injection Status and Outlook by Region
3.1 Global Flunixin Meglumine Injection Market Size and CAGR by Region: 2016 VS 2021 VS 2026
3.2 Global Flunixin Meglumine Injection Historic Market Size by Region
3.2.1 Global Flunixin Meglumine Injection Sales in Volume by Region (2016-2021)
3.2.2 Global Flunixin Meglumine Injection Sales in Value by Region (2016-2021)
3.2.3 Global Flunixin Meglumine Injection Sales (Volume & Value) Price and Gross Margin (2016-2021)
3.3 Global Flunixin Meglumine Injection Forecasted Market Size by Region
3.3.1 Global Flunixin Meglumine Injection Sales in Volume by Region (2022-2027)
3.3.2 Global Flunixin Meglumine Injection Sales in Value by Region (2022-2027)
3.3.3 Global Flunixin Meglumine Injection Sales (Volume & Value), Price and Gross Margin (2022-2027)

4 Global Flunixin Meglumine Injection by Application
4.1 Flunixin Meglumine Injection Market Segment by Application
4.1.1 Animal muscle pain
4.1.2 Animal febrile disease
4.1.3 Others
4.2 Global Flunixin Meglumine Injection Market Size by Application
4.2.1 Global Flunixin Meglumine Injection Market Size Overview by Application (2016-2027)
4.2.2 Global Flunixin Meglumine Injection Historic Market Size Review by Application (2016-2021)
4.2.2.1 Global Flunixin Meglumine Injection Sales Breakdown in Volume, by Application (2016-2021)
4.2.2.2 Global Flunixin Meglumine Injection Sales Breakdown in Value, by Application (2016-2021)
4.2.2.3 Global Flunixin Meglumine Injection Average Selling Price (ASP) by Application (2016-2021)
4.2.3 Global Flunixin Meglumine Injection Forecasted Market Size by Application (2022-2027)
4.2.3.1 Global Flunixin Meglumine Injection Sales Breakdown in Volume, by Application (2022-2027)
4.2.3.2 Global Flunixin Meglumine Injection Sales Breakdown in Value, by Application (2022-2027)
4.2.3.3 Global Flunixin Meglumine Injection Average Selling Price (ASP) by Application (2022-2027)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Flunixin Meglumine Injection Sales Breakdown by Application (2016-2021)
4.3.2 Europe Flunixin Meglumine Injection Sales Breakdown by Application (2016-2021)
4.3.3 Asia-Pacific Flunixin Meglumine Injection Sales Breakdown by Application (2016-2021)
4.3.4 Latin America Flunixin Meglumine Injection Sales Breakdown by Application (2016-2021)
4.3.5 Middle East and Africa Flunixin Meglumine Injection Sales Breakdown by Application (2016-2021)

5 North America Flunixin Meglumine Injection by Country
5.1 North America Flunixin Meglumine Injection Historic Market Size by Country
5.1.1 North America Flunixin Meglumine Injection Sales in Volume by Country (2016-2021)
5.1.2 North America Flunixin Meglumine Injection Sales in Value by Country (2016-2021)
5.2 North America Flunixin Meglumine Injection Forecasted Market Size by Country
5.2.1 North America Flunixin Meglumine Injection Sales in Volume by Country (2022-2027)
5.2.2 North America Flunixin Meglumine Injection Sales in Value by Country (2022-2027)

6 Europe Flunixin Meglumine Injection by Country
6.1 Europe Flunixin Meglumine Injection Historic Market Size by Country
6.1.1 Europe Flunixin Meglumine Injection Sales in Volume by Country (2016-2021)
6.1.2 Europe Flunixin Meglumine Injection Sales in Value by Country (2016-2021)
6.2 Europe Flunixin Meglumine Injection Forecasted Market Size by Country
6.2.1 Europe Flunixin Meglumine Injection Sales in Volume by Country (2022-2027)
6.2.2 Europe Flunixin Meglumine Injection Sales in Value by Country (2022-2027)

7 Asia-Pacific Flunixin Meglumine Injection by Region
7.1 Asia-Pacific Flunixin Meglumine Injection Historic Market Size by Region
7.1.1 Asia-Pacific Flunixin Meglumine Injection Sales in Volume by Region (2016-2021)
7.1.2 Asia-Pacific Flunixin Meglumine Injection Sales in Value by Region (2016-2021)
7.2 Asia-Pacific Flunixin Meglumine Injection Forecasted Market Size by Region
7.2.1 Asia-Pacific Flunixin Meglumine Injection Sales in Volume by Region (2022-2027)
7.2.2 Asia-Pacific Flunixin Meglumine Injection Sales in Value by Region (2022-2027)

8 Latin America Flunixin Meglumine Injection by Country
8.1 Latin America Flunixin Meglumine Injection Historic Market Size by Country
8.1.1 Latin America Flunixin Meglumine Injection Sales in Volume by Country (2016-2021)
8.1.2 Latin America Flunixin Meglumine Injection Sales in Value by Country (2016-2021)
8.2 Latin America Flunixin Meglumine Injection Forecasted Market Size by Country
8.2.1 Latin America Flunixin Meglumine Injection Sales in Volume by Country (2022-2027)
8.2.2 Latin America Flunixin Meglumine Injection Sales in Value by Country (2022-2027)

9 Middle East and Africa Flunixin Meglumine Injection by Country
9.1 Middle East and Africa Flunixin Meglumine Injection Historic Market Size by Country
9.1.1 Middle East and Africa Flunixin Meglumine Injection Sales in Volume by Country (2016-2021)
9.1.2 Middle East and Africa Flunixin Meglumine Injection Sales in Value by Country (2016-2021)
9.2 Middle East and Africa Flunixin Meglumine Injection Forecasted Market Size by Country
9.2.1 Middle East and Africa Flunixin Meglumine Injection Sales in Volume by Country (2022-2027)
9.2.2 Middle East and Africa Flunixin Meglumine Injection Sales in Value by Country (2022-2027)

10 Company Profiles and Key Figures in Flunixin Meglumine Injection Business
10.1 Norbrook
10.1.1 Norbrook Corporation Information
10.1.2 Norbrook Introduction and Business Overview
10.1.3 Norbrook Flunixin Meglumine Injection Sales, Revenue and Gross Margin (2016-2021)
10.1.4 Norbrook Flunixin Meglumine Injection Products Offered
10.1.5 Norbrook Recent Development
10.2 Zoteis
10.2.1 Zoteis Corporation Information
10.2.2 Zoteis Introduction and Business Overview
10.2.3 Zoteis Flunixin Meglumine Injection Sales, Revenue and Gross Margin (2016-2021)
10.2.4 Zoteis Flunixin Meglumine Injection Products Offered
10.2.5 Zoteis Recent Development
10.3 Merck Animal Health
10.3.1 Merck Animal Health Corporation Information
10.3.2 Merck Animal Health Introduction and Business Overview
10.3.3 Merck Animal Health Flunixin Meglumine Injection Sales, Revenue and Gross Margin (2016-2021)
10.3.4 Merck Animal Health Flunixin Meglumine Injection Products Offered
10.3.5 Merck Animal Health Recent Development
10.4 Virbac Animal Health India Private Limited
10.4.1 Virbac Animal Health India Private Limited Corporation Information
10.4.2 Virbac Animal Health India Private Limited Introduction and Business Overview
10.4.3 Virbac Animal Health India Private Limited Flunixin Meglumine Injection Sales, Revenue and Gross Margin (2016-2021)
10.4.4 Virbac Animal Health India Private Limited Flunixin Meglumine Injection Products Offered
10.4.5 Virbac Animal Health India Private Limited Recent Development
10.5 MSD Animal Health
10.5.1 MSD Animal Health Corporation Information
10.5.2 MSD Animal Health Introduction and Business Overview
10.5.3 MSD Animal Health Flunixin Meglumine Injection Sales, Revenue and Gross Margin (2016-2021)
10.5.4 MSD Animal Health Flunixin Meglumine Injection Products Offered
10.5.5 MSD Animal Health Recent Development
10.6 Bengal Remedies Limited
10.6.1 Bengal Remedies Limited Corporation Information
10.6.2 Bengal Remedies Limited Introduction and Business Overview
10.6.3 Bengal Remedies Limited Flunixin Meglumine Injection Sales, Revenue and Gross Margin (2016-2021)
10.6.4 Bengal Remedies Limited Flunixin Meglumine Injection Products Offered
10.6.5 Bengal Remedies Limited Recent Development
10.7 Wuhan Huisheng Biological Technology Co., Ltd.
10.7.1 Wuhan Huisheng Biological Technology Co., Ltd. Corporation Information
10.7.2 Wuhan Huisheng Biological Technology Co., Ltd. Introduction and Business Overview
10.7.3 Wuhan Huisheng Biological Technology Co., Ltd. Flunixin Meglumine Injection Sales, Revenue and Gross Margin (2016-2021)
10.7.4 Wuhan Huisheng Biological Technology Co., Ltd. Flunixin Meglumine Injection Products Offered
10.7.5 Wuhan Huisheng Biological Technology Co., Ltd. Recent Development
10.8 Qilu Animal Health Products Co., Ltd.
10.8.1 Qilu Animal Health Products Co., Ltd. Corporation Information
10.8.2 Qilu Animal Health Products Co., Ltd. Introduction and Business Overview
10.8.3 Qilu Animal Health Products Co., Ltd. Flunixin Meglumine Injection Sales, Revenue and Gross Margin (2016-2021)
10.8.4 Qilu Animal Health Products Co., Ltd. Flunixin Meglumine Injection Products Offered
10.8.5 Qilu Animal Health Products Co., Ltd. Recent Development
10.9 Baimukang Animal Pharmaceutical Co., Ltd.
10.9.1 Baimukang Animal Pharmaceutical Co., Ltd. Corporation Information
10.9.2 Baimukang Animal Pharmaceutical Co., Ltd. Introduction and Business Overview
10.9.3 Baimukang Animal Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Sales, Revenue and Gross Margin (2016-2021)
10.9.4 Baimukang Animal Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Products Offered
10.9.5 Baimukang Animal Pharmaceutical Co., Ltd. Recent Development
10.10 Shandong Zhongmu Veterinary Medicine Co., Ltd.
10.10.1 Company Basic Information, Manufacturing Base and Competitors
10.10.2 Flunixin Meglumine Injection Product Category, Application and Specification
10.10.3 Shandong Zhongmu Veterinary Medicine Co., Ltd. Flunixin Meglumine Injection Sales, Revenue, Price and Gross Margin (2016-2021)
10.10.4 Main Business Overview
10.10.5 Shandong Zhongmu Veterinary Medicine Co., Ltd. Recent Development
10.11 Hebei New Century Pharmaceutical Co., Ltd.
10.11.1 Hebei New Century Pharmaceutical Co., Ltd. Corporation Information
10.11.2 Hebei New Century Pharmaceutical Co., Ltd. Introduction and Business Overview
10.11.3 Hebei New Century Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Sales, Revenue and Gross Margin (2016-2021)
10.11.4 Hebei New Century Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Products Offered
10.11.5 Hebei New Century Pharmaceutical Co., Ltd. Recent Development
10.12 Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd.
10.12.1 Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd. Corporation Information
10.12.2 Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd. Introduction and Business Overview
10.12.3 Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Sales, Revenue and Gross Margin (2016-2021)
10.12.4 Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Products Offered
10.12.5 Jiangsu Nannong High-tech Animal Pharmaceutical Co., Ltd. Recent Development
10.13 Shandong Lukang Pharmaceutical Co., Ltd.
10.13.1 Shandong Lukang Pharmaceutical Co., Ltd. Corporation Information
10.13.2 Shandong Lukang Pharmaceutical Co., Ltd. Introduction and Business Overview
10.13.3 Shandong Lukang Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Sales, Revenue and Gross Margin (2016-2021)
10.13.4 Shandong Lukang Pharmaceutical Co., Ltd. Flunixin Meglumine Injection Products Offered
10.13.5 Shandong Lukang Pharmaceutical Co., Ltd. Recent Development

11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Flunixin Meglumine Injection Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Flunixin Meglumine Injection Industrial Chain Analysis
11.4 Flunixin Meglumine Injection Market Dynamics
11.4.1 Industry Trends
11.4.2 Market Drivers
11.4.3 Market Challenges
11.4.4 Market Restraints

12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Flunixin Meglumine Injection Distributors
12.3 Flunixin Meglumine Injection Downstream Customers

13 Research Findings and Conclusion

14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
  • FORMAT: PDF
  • PUBLISHED DATE: Jun, 2021
  • NO OF PAGES: 140